Cargando…

Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303

Esophageal fistula is a critical adverse event in patients treated with chemoradiotherapy (CRT) for locally advanced esophageal cancer. However, risk factors associated with esophageal fistula formation in patients receiving CRT have not yet been elucidated. We retrospectively analyzed data obtained...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsushima, Takahiro, Mizusawa, Junki, Sudo, Kazuki, Honma, Yoshitaka, Kato, Ken, Igaki, Hiroyasu, Tsubosa, Yasuhiro, Shinoda, Masayuki, Nakamura, Kenichi, Fukuda, Haruhiko, Kitagawa, Yuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902424/ https://www.ncbi.nlm.nih.gov/pubmed/27196482 http://dx.doi.org/10.1097/MD.0000000000003699

Ejemplares similares

Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303)
por: Okuno, Tatsuya, et al.
Publicado: (2017)

Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)
por: Shinoda, Masayuki, et al.
Publicado: (2015)

Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)
por: Hironaka, Shuichi, et al.
Publicado: (2014)

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)
por: Tahara, Makoto, et al.
Publicado: (2015)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
por: Tahara, Makoto, et al.
Publicado: (2015)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Impact of laparoscopy on the prevention of pulmonary complications after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2017)

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502
por: Mitani, Seiichiro, et al.
Publicado: (2022)

Aortic Pseudoaneurysm Formation Following Concurrent Chemoradiotherapy And Metallic Stent Insertion in a Patient With Esophageal Cancer
por: Hou, Pei-Yu, et al.
Publicado: (2015)

Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2015)

Factors Associated With False-Negative Endoscopic Biopsy Results After Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
por: Chao, Yin-Kai, et al.
Publicado: (2015)

Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Yang, Xiyue, et al.
Publicado: (2021)

Erratum to: Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2015)

Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study
por: Zhao, Qian, et al.
Publicado: (2017)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute
por: Jing, Wang, et al.
Publicado: (2016)

Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: Experience from a single institution
por: Kozu, Yoshiki, et al.
Publicado: (2011)

Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach
por: Giorgetti, Assuero, et al.
Publicado: (2016)

Retrograde Lymphatic Spread of Esophageal Cancer: A Case Report
por: Oshiro, Hisashi, et al.
Publicado: (2015)

Brain metastases from esophageal cancer: A case report
por: Qie, Shuai, et al.
Publicado: (2020)

Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancer
por: Lv, Yajuan, et al.
Publicado: (2020)

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009)

Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304
por: Tanaka, Kazuhiro, et al.
Publicado: (2016)

Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Analysis on plausible factors related to the prognosis of stage IV esophageal cancer
por: Li, Chenghui, et al.
Publicado: (2020)

Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
por: Zhang, Guoqing, et al.
Publicado: (2019)

Esophageal peripheral T-cell lymphoma treated with radiotherapy: A case report
por: Zhang, Qiujing, et al.
Publicado: (2021)

Identification of potential core genes in esophageal carcinoma using bioinformatics analysis
por: Yang, Xiaojie, et al.
Publicado: (2021)

Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer
por: Hou, Jun, et al.
Publicado: (2022)

A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma
por: Satake, Hironaga, et al.
Publicado: (2016)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

Salvage radiochemotherapy for lymph node recurrence after radical surgery of esophageal cancer
por: Zhou, Yi-Qin, et al.
Publicado: (2018)

Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis
por: Xu, Bo, et al.
Publicado: (2017)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Surgery and postoperative radiotherapy affect the prognosis of esophageal cancer: A SEER analysis
por: Yang, Wenwen, et al.
Publicado: (2023)

Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma
por: Zhou, Lu, et al.
Publicado: (2023)

Risk factors for the development of postoperative atrial fibrillation after esophagectomy for esophageal cancer
por: He, Feng, et al.
Publicado: (2023)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Association between ALDH2 Glu487Lys polymorphism and the risk of esophageal cancer
por: Liu, Kang, et al.
Publicado: (2017)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_22t2t01ebot7qhmk6djopkh403